{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:01:39Z","timestamp":1789621299644,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001769","name":"Charles Sturt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.127989","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T16:47:02Z","timestamp":1763311622000},"page":"127989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Safety and immunogenicity of a novel psittacine beak and feather disease vaccine and optimisation of a thermostable spray-dried formulation"],"prefix":"10.1016","volume":"69","author":[{"given":"Tridip","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu K.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pangkaj K.","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade K.","family":"Forwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane R.","family":"Raidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhagata","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127989_bb0005","series-title":"Post-graduate Committee in Veterinary Science: 1981","first-page":"81","article-title":"Aviary and cased birds","author":"Perry","year":"1981"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127989_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1751-0813.1993.tb06104.x","article-title":"Laboratory diagnosis of psittacine beak and feather disease by haemagglutination and haemagglutination inhibition","volume":"70","author":"Raidal","year":"1993","journal-title":"Aust. Vet. J."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1006\/viro.2000.0847","article-title":"Genetic diversity of beak and feather disease virus detected in psittacine species in Australia","volume":"279","author":"Bassami","year":"2001","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0042-6822(02)00048-X","article-title":"Evidence for specificity of psittacine beak and feather disease viruses among avian hosts","volume":"306","author":"Ritchie","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127989_bb0025","series-title":"Current therapy in avian medicine and surgery","first-page":"51","article-title":"Psittacine beak and feather disease","author":"Raidal","year":"2016"},{"key":"10.1016\/j.vaccine.2025.127989_bb0030","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9211","article-title":"A non-invasive method to assess environmental contamination with avian pathogens: beak and feather disease virus (BFDV) detection in nest boxes","volume":"8","author":"Martens","year":"2020","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127989_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/03079459408419032","article-title":"The haemagglutination spectrum of psittacine beak and feather disease virus","volume":"23","author":"Raidal","year":"1994","journal-title":"Avian Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/01584197.2017.1387029","article-title":"Psittacine beak and feather disease: ecology and implications for conservation","volume":"118","author":"Raidal","year":"2018","journal-title":"Emu Austral Ornithol."},{"key":"10.1016\/j.vaccine.2025.127989_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ympev.2016.04.024","article-title":"Evolution of circoviruses in lorikeets lags behind its hosts","volume":"100","author":"Das","year":"2016","journal-title":"Mol. Phylogenet. Evol."},{"issue":"12","key":"10.1016\/j.vaccine.2025.127989_bb0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/avj.12388","article-title":"Review of psittacine beak and feather disease and its effect on Australian endangered species","volume":"93","author":"Raidal","year":"2015","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.vaccine.2025.127989_bb0055","series-title":"Conference proceedings (G Cross, ed) Association of Avian Veterinarians, Australian Committee Currumbin","first-page":"11","article-title":"Control of psittacine beak and feather disease (PBFD) by vaccination","volume":"1994","author":"Raidal","year":"1994"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127989_bb0060","first-page":"178","article-title":"Control by vaccination of psittacine beak and feather disease in a mixed flock of Agapornis spp","volume":"24","author":"Raidal","year":"1994","journal-title":"Aust. Vet. Pract."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0065","first-page":"55","article-title":"Psittacine beak and feather disease-an update","volume":"15","author":"Pass","year":"1985","journal-title":"Aust. Vet. Pract."},{"key":"10.1016\/j.vaccine.2025.127989_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2015.02.005","article-title":"An efficient approach for recombinant expression and purification of the viral capsid protein from beak and feather disease virus (BFDV) in Escherichia coli","volume":"215-216","author":"Sarker","year":"2015","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vaccine.2025.127989_bb0075","unstructured":"Das S, Sarker S, Nath B, Gill J, Shearer P, Peters A, Forwood J, White M, Raidal S: Vaccination strategies for PBFD. In: 2019 wildlife disease association Australasia (WDA-A) conference: 29 Sept 2019 2019; Tasmania, Australia; 2019."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/03079458708436374","article-title":"Experimental reproduction of psittacine beak and feather disease\/French Moult","volume":"16","author":"Wylie","year":"1987","journal-title":"Avian Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.sbi.2012.02.003","article-title":"Insect virus polyhedra, infectious protein crystals that contain virus particles","volume":"22","author":"Chiu","year":"2012","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"52","key":"10.1016\/j.vaccine.2025.127989_bb0090","doi-asserted-by":"crossref","first-page":"22205","DOI":"10.1073\/pnas.0910686106","article-title":"The atomic structure of baculovirus polyhedra reveals the independent emergence of infectious crystals in DNA and RNA viruses","volume":"106","author":"Coulibaly","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2025.127989_bb0095","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.ddtec.2008.11.001","article-title":"Drying methods for protein pharmaceuticals","volume":"5","author":"Maltesen","year":"2008","journal-title":"Drug Discov. Today Technol."},{"issue":"31","key":"10.1016\/j.vaccine.2025.127989_bb0100","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2010.04.112","article-title":"Thermostable formulations of a hepatitis B vaccine and a meningitis a polysaccharide conjugate vaccine produced by a spray drying method","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127989_bb0105","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.molpharmaceut.6b00072","article-title":"Optimized formulation of a thermostable spray-dried virus-like particle vaccine against human papillomavirus","volume":"13","author":"Saboo","year":"2016","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.vaccine.2025.127989_bb0110","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1080\/21645515.2017.1356952","article-title":"Have Rt, Soema PC, Frijlink H, Amorij J-P, Kersten G: developments in the formulation and delivery of spray dried vaccines","volume":"13","author":"Kanojia","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0115","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijpharm.2016.08.022","article-title":"A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine","volume":"511","author":"Kanojia","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1208\/s12248-010-9179-z","article-title":"Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures","volume":"12","author":"Geeraedts","year":"2010","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.vaccine.2025.127989_bb0125","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.vaccine.2009.11.024","article-title":"Heat-stable measles vaccine produced by spray drying","volume":"28","author":"Ohtake","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127989_bb0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2014.04.021","article-title":"Phylogeny of beak and feather disease virus in cockatoos demonstrates host generalism and multiple-variant infections within Psittaciformes","volume":"460-461","author":"Sarker","year":"2014","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pep.2007.01.013","article-title":"New vectors for co-expression of proteins: structure of Bacillus subtilis ScoAB obtained by high-throughput protocols","volume":"53","author":"Stols","year":"2007","journal-title":"Protein Expr. Purif."},{"issue":"13","key":"10.1016\/j.vaccine.2025.127989_bb0140","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/bi00789a030","article-title":"Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane","volume":"10","author":"Fairbanks","year":"1971","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jviromet.2013.01.020","article-title":"Differential expression of two isolates of beak and feather disease virus capsid protein in Escherichia coli","volume":"189","author":"Patterson","year":"2013","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0150","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11259-023-10290-z","article-title":"Recombinantly expressed virus-like particles (VLPs) of canine circovirus for development of an indirect ELISA","volume":"48","author":"Neef","year":"2024","journal-title":"Vet. Res. Commun."},{"issue":"12","key":"10.1016\/j.vaccine.2025.127989_bb0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/avj.12649","article-title":"Beak and feather disease virus carriage by Knemidocoptes pilae in a Sulphur-crested cockatoo (Cacatua galerita)","volume":"95","author":"Portas","year":"2017","journal-title":"Aust. Vet. J."},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2025.127989_bb0170","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1099\/vir.0.006932-0","article-title":"Assessment of recombinant beak and feather disease virus capsid protein as a vaccine for psittacine beak and feather disease","volume":"90","author":"Bonne","year":"2009","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127989_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00580-009-0811-1","article-title":"Hematology of vaccinated and non-vaccinated long-billed corellas following infection with beak and feather disease virus (BFDV)","volume":"18","author":"Bonne","year":"2009","journal-title":"Comp. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41541-020-00238-8","article-title":"O\u2019hagan DT: technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines","volume":"5","author":"Lofano","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.127989_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2018.07.035","article-title":"Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization","volume":"286","author":"Kanojia","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vaccine.2025.127989_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120121","article-title":"Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate","volume":"593","author":"Gomez","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"50","key":"10.1016\/j.vaccine.2025.127989_bb0195","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1016\/j.vaccine.2014.09.071","article-title":"Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled phase I clinical trial","volume":"32","author":"Cape","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1208\/s12249-016-0566-3","article-title":"Physicochemical and preclinical evaluation of a novel buccal measles vaccine","volume":"18","author":"Gala","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127989_bb0205","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.0800043105","article-title":"Immunization by a bacterial aerosol","volume":"105","author":"Garcia-Contreras","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127989_bb0210","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1073\/pnas.1017334108","article-title":"Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques","volume":"108","author":"Lin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127989_bb0215","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1208\/s12248-010-9192-2","article-title":"Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary route","volume":"12","author":"Muttil","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.vaccine.2025.127989_bb0220","unstructured":"Psittacine beak and feather disease [https:\/\/www.dcceew.gov.au\/environment\/invasive-species\/diseases-fungi-and-parasites\/beak-and-feather-disease]."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127989_bb0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2307\/1592565","article-title":"Severe leukopenia and liver necrosis in young African grey parrots (Psittacus erithacus erithacus) infected with psittacine circovirus","volume":"44","author":"Schoemaker","year":"2000","journal-title":"Avian Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2025.127989_bb0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2010.55","article-title":"Topical immunization strategies","volume":"3","author":"Czerkinsky","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.vaccine.2025.127989_bb0235","doi-asserted-by":"crossref","unstructured":"G. Popova P, Chen SP, Liao S, Sadarangani M, Blakney AK: Clinical perspective on topical vaccination strategies. Adv. Drug Deliv. Rev. 2024, 208:115292.","DOI":"10.1016\/j.addr.2024.115292"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127989_bb0240","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaerosci.2007.04.005","article-title":"Particle formation in spray drying","volume":"38","author":"Vehring","year":"2007","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.vaccine.2025.127989_bb0245","series-title":"Pharmaceutical quality by design","first-page":"43","article-title":"Chapter 3 - application of Design of Experiments (DoE) in pharmaceutical product and process optimization","author":"Beg","year":"2019"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127989_bb0250","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"D MR: design of experiments (DoE) in pharmaceutical development","volume":"43","author":"Politis","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.vaccine.2025.127989_bb0255","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1365-2672.2002.01782.x","article-title":"Improved survival of lactobacillus paracasei NFBC 338 in spray-dried powders containing gum acacia","volume":"93","author":"Desmond","year":"2002","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.vaccine.2025.127989_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fbp.2024.05.017","article-title":"Sobral PJdA, Vega-Castro O: design and optimization of a strawberry-based dispersion to produce a spray drying functional powdered product, fortified with folic acid and zinc","volume":"147","author":"Henao-Gonz\u00e1lez","year":"2024","journal-title":"Food Bioprod. Process."},{"key":"10.1016\/j.vaccine.2025.127989_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1208\/pt030104","article-title":"Statistical modeling of protein spray drying at the lab scale","volume":"3","author":"Prinn","year":"2002","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vaccine.2025.127989_bb0270","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1007\/s11095-013-1096-2","article-title":"Engineering of an inhalable DDA\/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process","volume":"30","author":"Ingvarsson","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.vaccine.2025.127989_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2023.100031","article-title":"The effect of particle size on drug bioavailability in various parts of the body","volume":"2","author":"Mok","year":"2024","journal-title":"Pharmaceutical Sci Adv"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2025.127989_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.607945","article-title":"Modulation of immune responses by particle size and shape","volume":"11","author":"Baranov","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.vaccine.2025.127989_bb0290","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1007\/s11095-014-1394-3","article-title":"Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up","volume":"31","author":"Zhu","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.vaccine.2025.127989_bb0300","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2017.01.024","article-title":"How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions","volume":"114","author":"Mensink","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"10.1016\/j.vaccine.2025.127989_bb0305","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/jps.21825","article-title":"Mechanisms of protein stabilization in the solid state","volume":"98","author":"Chang","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.vaccine.2025.127989_bb0310","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1007\/s11095-011-0658-4","article-title":"The effect of water plasticization on the molecular mobility and crystallization tendency of amorphous disaccharides","volume":"29","author":"Heljo","year":"2012","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0315","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2016.06.038","article-title":"Spray-dried amorphous isomalt and melibiose, two potential protein-stabilizing excipients","volume":"510","author":"Lipi\u00e4inen","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"27","key":"10.1016\/j.vaccine.2025.127989_bb0320","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.vaccine.2016.04.036","article-title":"Optimized polypeptide for a subunit vaccine against avian reovirus","volume":"34","author":"Goldenberg","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127989_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00658-19","article-title":"A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene","volume":"4","author":"Conradie","year":"2019","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11095-014-1454-8","article-title":"Co-spray dried carbohydrate microparticles: crystallisation delay\/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-\u03b2-cyclodextrin with amorphous raffinose or trehalose","volume":"32","author":"Amaro","year":"2015","journal-title":"Pharm. Res."},{"issue":"23","key":"10.1016\/j.vaccine.2025.127989_bb0335","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1016\/j.vaccine.2020.03.060","article-title":"Comparative evaluation of ELPylated virus-like particle vaccine with two commercial PCV2 vaccines by experimental challenge","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127989_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39621","article-title":"Clarification of a unique mucosal vaccination route for improved systemic and mucosal immune response in broiler","volume":"10","author":"Akter","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2025.127989_bb0345","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnut.2018.00060","article-title":"The well-developed mucosal immune Systems of Birds and Mammals Allow for similar approaches of mucosal vaccination in both types of animals","volume":"5","author":"Nochi","year":"2018","journal-title":"Front Nutr"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127989_bb0350","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127989_bb0355","series-title":"Vaccine adjuvants and delivery systems","author":"Singh","year":"2007"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127989_bb0360","article-title":"Chitosan-based nanomaterial as immune adjuvant and delivery carrier for vaccines","volume":"10","author":"Gong","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127989_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28124778","article-title":"Poloxamers Have vaccine-adjuvant properties by increasing dissemination of particulate antigen at distant lymph nodes","volume":"28","author":"Lamrayah","year":"2023","journal-title":"Molecules"},{"issue":"50","key":"10.1016\/j.vaccine.2025.127989_bb0370","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1016\/j.vaccine.2010.09.087","article-title":"Ruiz RdC, Scaramuzzi K, Marengo EB, Matos JR, Tambourgi DV, Fantini MC, Sant\u2019Anna OA: immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15","volume":"28","author":"Carvalho","year":"2010","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2025.127989_bb0375","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1016\/j.vaccine.2014.04.043","article-title":"Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation","volume":"32","author":"Wibowo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127989_bb0380","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fmicb.2017.00927","article-title":"Antigen-sparing and enhanced efficacy of multivalent vaccines Adjuvanted with Immunopotentiators in chickens","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0385","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"COMMENTARY: acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.vaccine.2025.127989_bb0390","first-page":"2431","article-title":"Oral administration of lipopolysaccharides for the prevention of various diseases: benefit and usefulness","volume":"31","author":"Inagawa","year":"2011","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0395","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/1589684","article-title":"Toxicity of endotoxin to chicks","volume":"23","author":"Adler","year":"1979","journal-title":"Avian Dis."},{"issue":"7","key":"10.1016\/j.vaccine.2025.127989_bb0400","article-title":"Relationship between endotoxin content in vaccine preclinical formulations and animal welfare: an extensive study on historical data to set an informed threshold","volume":"12","author":"Baffetta","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127989_bb0405","article-title":"Nanovaccines against animal pathogens: the latest findings","volume":"9","author":"Celis-Giraldo","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127989_bb0410","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/birds6010004","article-title":"The Heterophil-to-lymphocyte (H\/L) ratio indicates varying physiological characteristics in nestlings compared to adults in a long-lived seabird","volume":"6","author":"Br\u00e5then","year":"2025","journal-title":"Birds"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:29:32Z","timestamp":1766089772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25012873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":79,"alternative-id":["S0264410X25012873"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127989","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of a novel psittacine beak and feather disease vaccine and optimisation of a thermostable spray-dried formulation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127989"}}